Biofilm testing of Staphylococcus epidermidis clinical isolates:: low performance of vancomycin in relation to other antibiotics

被引:86
作者
Monzón, M
Oteiza, C
Leiva, J
Lamata, M
Amorena, B
机构
[1] CSIC, Dept Anim Hlth & Prod, SIA, DGA, Zaragoza 50080, Spain
[2] UPNA, CSIC, Inst Agrobiotechnol & Nat Resources, Pamplona 31192, Spain
[3] Univ Navarra Clin, Dept Microbiol, Pamplona 31080, Spain
关键词
D O I
10.1016/S0732-8893(02)00464-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro killing effect of widely used antibiotics (cephalothin, clindamycin, erythromycin, ofloxacin, rifampicin, teicoplanin, tetracycline, phosphomycin and vancomycin) was comparatively analyzed in this study on 24-h biofilms of 64 Staphylococcus epidermidis clinical isolates. This effect was assessed at the expected antibiotic concentration reached in serum, using ATP-bioluminescence. Erythromycin, rifampicin, tetracycline and phosphomycin presented generally a higher killing effect than vancomycin, clindamycin, cephalothin, teicoplanin and ofloxacin in these biofilms. Differences in the resistance profiles obtained in classical assays (broth microdilution and diffusion) did not help to predict differences in the killing effect of the antibiotics in biofilms. Only some antibiotics (vancomycin but not rifampicin or tetracycline) highly decreased their killing effect as the biofilm age increased (from 6 to 24 or 48 h). These studies underline the relevance of biofilm susceptibility testing and the potential danger of the indiscriminate use of vancomycin monotherapy as the ultimate resource against infections involving aged biofilms. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 38 条
[1]   Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro [J].
Amorena, B ;
Gracia, E ;
Monzón, M ;
Leiva, J ;
Oteiza, C ;
Pérez, M ;
Alabart, JL ;
Hernández-Yago, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :43-55
[2]  
[Anonymous], 1997, M7A5 NCCLS, V20
[3]   INTERACTION OF BIOFILM BACTERIA WITH ANTIBIOTICS IN A NOVEL INVITRO CHEMOSTAT SYSTEM [J].
ANWAR, H ;
VANBIESEN, T ;
DASGUPTA, M ;
LAM, K ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1824-1826
[4]   ESTABLISHMENT OF AGING BIOFILMS - POSSIBLE MECHANISM OF BACTERIAL-RESISTANCE TO ANTIMICROBIAL THERAPY [J].
ANWAR, H ;
STRAP, JL ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) :1347-1351
[5]  
BADDOUR LM, 1987, REV INFECT DIS, V9, P1168
[6]   Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal β-lactamase [J].
Bagge, N ;
Ciofu, O ;
Skovgaard, LT ;
Hoiby, N .
APMIS, 2000, 108 (09) :589-600
[7]   RESISTANCE OF BACTERIAL BIOFILMS TO ANTIBIOTICS - A GROWTH-RATE RELATED EFFECT [J].
BROWN, MRW ;
ALLISON, DG ;
GILBERT, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (06) :777-780
[8]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776
[9]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[10]   MICROBIAL BIOFILMS [J].
COSTERTON, JW ;
LEWANDOWSKI, Z ;
CALDWELL, DE ;
KORBER, DR ;
LAPPINSCOTT, HM .
ANNUAL REVIEW OF MICROBIOLOGY, 1995, 49 :711-745